Healthcare

AusCann Group Holdings Ltd (ASX:AC8)

Industry Group : Pharmaceuticals, Biotechnology & Life Sciences | Industry Group Name : Pharmaceuticals

Market Price : AUD 0.0920.002 (2.222%)

(as on 2021-09-27 00:15:05)

Market Cap : AUD 40.53 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.09 0.09 0.092 0.09L 0.093 H 0.084L 0.3 H
Last Trade 0.092
Change% 2.2222
52 W H/L 0.3/0.084
EBITDA -9.123 M
NPAT After Abnormal Items -8.641 M
Equity 44.428 M
ROE% -21.16%
Total Liabilities 691,665
Total Revenue 1.827 M
Cash and Cash Equivalents 13.68 M

Stock Information

Share price 0.092
Market Cap 40.53 M
Price/Gross Cash Flow -7.33
Dividend Yield Excluding Special 0.00%
Ending Shares 440.547 M
52-Week Range 0.084-0.3
P/E ratio 0.000
Sector P/E --
EPS -2.45
EV/EBITDA --
Net Profit Margin (%) -11,128.29%
Gross Cash Flows Per Share -0.02
Net Gearing -30.60%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.06
Sales Per Share 0.00
Book Value Per Share 0.10

Announcements

Heading Date/Time
AusCann to Accelerate Human Drug Development Program  21/09/2021 9:15AM
AusCann Appoints US Advisors to Advance CPAT-01 FDA Program  09/09/2021 8:20AM
Key Company Highlights & Financial Commentary for FY2021  30/08/2021 9:23AM
Appendix 4E and Annual Financial Statements  30/08/2021 9:21AM
Appendix 4G and Corporate Governance Statement  30/08/2021 9:18AM
Notification of cessation of securities - AC8  06/08/2021 7:04PM
June 2021 Quarterly Activities and Cashflow Reports  30/07/2021 9:33AM
AusCann Commences Australian Product Registration for Dogs  20/07/2021 8:57AM
AusCann Successful in Tender with Tasmanian Dept of Health  01/07/2021 9:26AM
AusCann Enters into Lease Agreement for R&D Facility  17/06/2021 8:24AM
Change of Director's Interest Notice - G. Starr  19/05/2021 9:11AM
CPAT-01 Improves Pain, Lameness and Quality of Life in Dogs  30/04/2021 8:46AM
March 2021 Quarterly Activities and Cashflow Reports  30/04/2021 8:03AM
AusCann Receives R&D Tax Incentive Refund of $1.6m  23/04/2021 8:33AM
Chief Executive Officer Terms of Appointment  23/04/2021 8:23AM
Change of Director's Interest Notice - M. Johnston  19/04/2021 7:28PM
Initial Director's Interest Notice x 3  01/04/2021 6:47PM
Presentation - Cannabis & Hemp Investment Conference  23/03/2021 8:33AM
Change of Director's Interest Notice x 3  22/03/2021 4:31PM
AusCann Receives US$500k for Sale of Chilean Joint Venture  22/03/2021 8:47AM
Appendix 2A  18/03/2021 8:20PM
Appendix 3G  18/03/2021 8:19PM
Change in substantial holding  18/03/2021 5:24PM
Implementation of CannPal Scheme of Arrangement  18/03/2021 12:06PM
Proposed issue of Securities - AC8  17/03/2021 4:29PM
Appendix 4D and Half-Year Financial Report 31 December 2020  26/02/2021 8:10AM
Executive Appointments  22/02/2021 12:31PM
Completion of Small Shareholding Sale Facility  12/02/2021 11:14AM
December 2020 Quarterly Activities and Cashflow Reports  29/01/2021 9:16AM

Similar Companies

Related Articles

Load More

About Company

AusCann Group Holdings Ltd (ASX: AC8) is engaged in manufacturing and offering clinically validated cannabinoid medicines and aims to assist Australian patients in every regard. It has operations that run through different phases like cultivation and production, manufacture and distribution of products. The group was earlier known as TW Holdings Limited, and has been into cannabis cultivation for quite some time. They started with medications for neuropathic and chronic pain and have been targeting the opportunity in Australia primarily ($9 billion).

Corporate Information

company address Level 5, 35 Havelock Street, WEST PERTH, WA, AUSTRALIA, 6005

company phone+61 8 6305 0705

company websitehttp://www.auscann.com.au/

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 0.00%
30/06/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Prelim) 2022-08-29 2022
Report (Interim) 2022-02-25 2022
Report (Annual) 2021-10-18 2021
Report (Annual) 2021-09-29 2021

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 84,495 3,204 -- -- --
Other Revenue 1.742 M 1.325 M 670,606 53,814 260,396
Total Revenue 1.827 M 1.328 M 670,606 53,814 260,396
Interest Income 76,930 385,328 861,770 235,064 98,584
Interest Expenses 0 0 0 0 0
Expenses -10.621 M -8.068 M -7.778 M -7.926 M -13.879 M
EBITDA -8.794 M -6.74 M -7.107 M -7.873 M -13.619 M
Depreciation and Amortization -685,794 -94,776 -56,242 -30,774 -121
Depreciation -231,455 -94,776 -56,242 -30,774 -121
Amortisation -454,339 0 0 0 0
EBIT -9.48 M -6.835 M -7.164 M -7.903 M -13.619 M
Pre Tax Profit -9.403 M -6.45 M -6.302 M -7.668 M -13.521 M
Tax Expense 0 0 0 0 0
Net Profit After Tax -9.403 M -6.45 M -6.302 M -7.668 M -13.521 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items -1.173 M -626,308 -1.347 M 0 -239,101
Reported Net Profit After Abnormal Items -8.641 M -7.076 M -7.649 M -7.668 M -13.76 M
Ending Shares 440.547 M 317.047 M 316.997 M 276.873 M 271.373 M
Weighted Average Shares 352.236 M 317.044 M 308.342 M 272.431 M 1.536 B
EPS After Abnormal Items (cents) -2.45 -2.23 -2.48 -2.81 -0.9
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 15.23 M 23.642 M 35.675 M 13.906 M 15.218 M
Total Non Current Assets 29.89 M 11.823 M 7.193 M 806,273 580,867
Total Assets 45.119 M 35.465 M 42.868 M 14.712 M 15.799 M
Total Current Liabilities 651,794 774,782 1.199 M 600,139 784,376
Total Non Current Liabilities 39,871 54,433 0 0 0
Total Liabilities 691,665 829,215 1.199 M 600,139 784,376
Net Assets 44.428 M 34.636 M 41.668 M 14.112 M 15.015 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -6.932 M -10.551 M -4.968 M -4.785 M -2.948 M
Net Invested Cash 1.476 M -5.559 M -7.78 M -1.368 M -944,579
Net Financing Cash Flows -29,548 -31,848 35.177 M 3.954 M 16.009 M
End Cash Position 13.68 M 19.166 M 35.307 M 12.878 M 15.077 M
Beginning Cash 19.166 M 35.307 M 12.878 M 15.077 M 2.961 M
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 13.68 M 19.166 M 35.307 M 12.878 M 15.077 M

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK